Latent tuberculosis infection: the 4-month course of rifampicin is safer than the 9-month course of isoniazid

Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials

  • Jonathon R Campbellet al
  • Rédigé par : Pr Pierre Tattevin
Different regimens have similar efficacy for the treatment of latent tuberculosis infection (LTI), including 3 months of isoniazid (INH)/rifampicin (RMP), 4 months of RMP, and 9 months of INH. Hence, tolerability is a major criteria to define the optimal regimen. Results In this post-hoc analysis of 2 open-label randomized trials comparing 4 months of RMP and 9 months of ...
Ce contenu est à destination des professionnels de santé. Merci de vous identifier.
This content is intended for healthcare professionals. Thank you for identifying yourself.

Déjà inscrit / Already registered ?

Créer un compte / Create an account

Créer un compte ne prend que quelques minutes et vous permettra d'accèder à l'ensemble des contenus du site.
Creating an account takes only instant and will allow you to access all the content of the website.